COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

Saved in:
Bibliographic Details
Published in:Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir Vol. 48; no. 7; pp. 631 - 634
Main Authors: Şen, Selçuk, Üresin, Ali Yağız
Format: Journal Article
Language:English
Published: Turkey KARE Publishing 01-10-2020
Subjects:
ace inhibitor
aliskiren
Amides
angiotensin receptor blocker
Angiotensin-Converting Enzyme 2
Antihypertensive Agents
Betacoronavirus
Coronavirus Infections - drug therapy
COVID-19
direct renin inhibitor
Fumarates
Humans
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral - drug therapy
Renin-Angiotensin System - drug effects
Renin-Angiotensin System - physiology
SARS-CoV-2
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1308-4488
1016-5169
DOI:10.5543/tkda.2020.64072